证券代码：600498 证券简称：烽火通信 公告编号：2025-077 烽火通信科技股份有限公司关于归还暂时补充流动资金的募集资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 一、募集资金暂时补充流动资金情况 烽火通信科技股份有限公司（以下简称"公司"）于2024年12月11日召开第九届董事会第五次临时会议， 审议通过了《关于使用部分闲置募集资金暂时补充流动资金的议案》，同意将部分闲置募集资金不超过 2.7亿元（含2.7亿元）人民币暂时补充流动资金，使用期限不超过12个月（自公司董事会审议批准之日 起计算），在有效期内上述额度可以滚动循环使用，并将根据工程进度提前安排归还募集资金，确保募 集资金投资项目的正常运行。具体内容详见上海证券交易所网站（www.sse.com.cn）及2024年12月12日 《中国证券报》《上海证券报》和《证券时报》披露的《烽火通信科技股份有限公司关于使用部分闲置 募集资金暂时补充流动资金的公告》（公告编号：2024-070）。 二、募集资金归还情况 根据公司募集资金投资项目的建设进度 ...

Core Viewpoint - Beijing Yubang Power Technology Co., Ltd. plans to add a new implementation location for its fundraising project, specifically the "Beijing Technology R&D Center and Headquarters Construction Project," at No. 6066, Donghai Avenue, Wuyuan Street, Haiyan County, Jiaxing City, Zhejiang Province [2][5]. Fundraising Basic Situation - The company has received approval from the China Securities Regulatory Commission to issue 4,108,060 convertible bonds, with a total fundraising amount of RMB 410.81 million. After deducting issuance costs of RMB 7.16 million, the net amount raised is RMB 403.65 million [2][4]. Fundraising Investment Project Basic Situation - As of November 30, 2025, the company has outlined the usage of the raised funds, with adjustments made due to the termination of certain sub-projects. The remaining funds will continue to be stored in a special account [4][5]. Increase in Implementation Location - The addition of the new location is aimed at improving the efficiency of fund usage and optimizing resource allocation without changing the investment direction, total investment amount, or implementation content of the fundraising projects [5][6]. Impact on the Company - The decision to add the new implementation location is based on the actual needs of the fundraising project and is expected to facilitate project implementation and enhance the efficiency of fund usage. It does not involve any changes to the fund's direction or usage, nor does it negatively impact the company's normal operations [6][8]. Review Procedures - The board of directors approved the addition of the new implementation location during meetings held on December 8, 2025, and this decision does not require shareholder approval [7][12].

格隆汇12月9日丨东亚药业(605177.SH)公布，本次结项的募投项目名称："特色新型药物制剂研发与生 产基地建设项目（一期）"及"年产3,685吨医药及中间体、4,320吨副产盐项目（一期）"（以下统称"募 投项目"）。本次节余金额为14,732.34万元，下一步的安排是：鉴于上述募投项目已全部实施完毕并达 到预定可使用状态，为合理配置资金，提高募集资金使用效率，结合公司实际情况，浙江东亚药业股份 有限公司（以下简称"公司"）拟将节余募集资金14,732.34万元（含利息手续费等，实际金额以资金转出 当日募集资金专户余额为准）永久性补充流动资金，用于公司日常生产经营。 ...

Core Viewpoint - The company has successfully raised a total of 2.104 billion yuan through its initial public offering, with a net amount of 1.942 billion yuan allocated for specific projects [1] Fundraising and Management - The company has established a dedicated account at China Merchants Bank for the management of the raised funds, specifically for the "Japan Intelligent Manufacturing Project" [1] - A four-party supervision agreement has been signed among the company, its wholly-owned subsidiary Chuan Yue Co., Ltd., China Merchants Bank, and Guotai Junan Securities to regulate the use of the funds [1] - As of November 28, 2025, the balance in the dedicated account is reported to be 0 USD/0 JPY [1] - The agreement outlines detailed responsibilities, fund usage supervision, and information inquiry protocols among the parties involved [1]

信濠光电公告称，公司首次公开发行股票募集资金净额18.95亿元，投资"黄石信博电子产品玻璃防护屏 建设项目"和"补充流动资金"。截至2025年12月3日，前者已达预定可使用状态，决定结项。该项目总投 资15亿元，累计投资10.62亿元。公司曾使用超募资金8760万元收购东莞骏达触控15%股权。目前节余 募集资金及剩余超募资金共5.36亿元，拟永久补充流动资金，该事项已通过董事会审议，需提交股东会 审议。 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会出具的《关于同意天合光能股份有限公司向不特定对象发行可转换公司债券 注册的批复》（证监许可〔2023〕157号）同意注册，天合光能股份有限公司（以下简称"公司"）向不 特定对象发行可转债8,864,751手（8,864.751万张），每张面值为人民币100元，募集资金总额 8,864,751,000.00元，扣除发行费用48,650,279.85元（不含增值税）后，募集资金净额为8,816,100,720.15 元。上述募集资金已全部到位，经容诚会计师事务所（特殊普通合伙）验证，并于2023年2月17日出具 了容诚验字[2023] 200Z0002号验资报告。 上述募集资金到账后，公司对募集资金采用了专户存储制度，并与保荐人、存放募集资金的商业银行签 署了募集资金专户存储监管协议。 二、本次新增开设募集资金专项账户情况 2025年12月8日，公司召开第三届董事会第三十八次会议，审议通过《关于新增开立募集资金专户并签 订三方监管协议的议 ...

Group 1 - The company has successfully completed its initial public offering (IPO) of 40,001,000 shares at a price of 12.55 RMB per share, raising a total of 502,012,550 RMB, with a net amount of 423,821,978.59 RMB after deducting issuance costs [2][3] - The company has established a special account for the raised funds and signed a four-party supervision agreement involving the company, its wholly-owned subsidiary, the sponsor, and the bank [3][4] - The board of directors has authorized the management to handle the specific matters related to the capital increase and loan to the subsidiary, including signing relevant agreements [3][4] Group 2 - The special account for the raised funds has been opened at China Merchants Bank, with a balance of 0 RMB as of December 2, 2025, and is designated solely for specific investment projects [6][7] - The four-party supervision agreement outlines the responsibilities of each party in managing and supervising the use of the raised funds, ensuring compliance with relevant laws and regulations [6][7][8] - The agreement stipulates that any withdrawals exceeding 50 million RMB or 20% of the net raised funds must be reported to the sponsor, ensuring transparency and accountability [8] Group 3 - The company has approved the use of temporarily idle over-raised funds, up to 23.5 million RMB, for cash management purposes, including purchasing safe and liquid financial products [11][12] - A dedicated settlement account for cash management has been established under the original raised funds account, specifically for managing over-raised funds [12] - The company emphasizes that this cash management will not affect the ongoing investment projects or the normal operations of the business, aiming to enhance the efficiency of fund utilization and increase investment returns [15][16]

公告显示，截至2025年11月30日，公司"年产120吨原料药建设项目"募集资金计划投资2.64亿元，募集 资金账户已累计投入1.36亿元。"智能化特色原料药配套产业链项目"募集资金计划投资1亿元，募集资 金账户已累计投入3675.90万元。 中证报中证网讯(王珞)12月8日晚，新天地（301277）发布公告称，公司于2025年12月6日召开第六届董 事会第九次会议和第六届监事会第九次会议，审议通过《关于募集资金投资项目结项并将节余募集资金 永久补充流动资金及注销募集资金专户的议案》。公司首次公开发行股票募集资金投资项目"年产120吨 原料药建设项目"和使用首次公开发行股票超募资金投资建设的"智能化特色原料药配套产业链项目"已 达到预定可使用状态，公司拟将上述项目进行结项，并将节余募集资金(含利息收入及现金管理收益 等，具体金额以资金转出当日募集资金专户余额为准)用于永久补充流动资金并注销募集资金专户。 新天地表示，本次"年产120吨原料药建设项目"和"智能化特色原料药配套产业链项目"结项并将节余募 集资金永久补充流动资金，有助于满足公司日常生产经营对流动资金的需求，可以提高公司经营效率， 符合公司及全体股东 ...

Group 1 - The company has been approved by the China Securities Regulatory Commission to issue 10,160,000 convertible bonds, raising a total of RMB 1,016,000,000, with a net amount of RMB 1,004,159,622.64 after deducting issuance costs [2][4] - The company has established a special account for the management of the raised funds and signed a four-party supervision agreement with the sponsor and the bank [5][8] - The special account is specifically for the "Shandong Ruilin Polymer Air Separation Supply Project" and must not be used for other purposes [8][9] Group 2 - The company held a board meeting on November 7, 2025, to approve changes to the investment scale of the fundraising project and to use surplus funds for loans to a subsidiary [4][5] - The four-party supervision agreement includes provisions for the management and use of the raised funds, ensuring compliance with relevant laws and regulations [8][10] - The agreement stipulates that the sponsor has the right to supervise the use of the funds and must conduct checks every six months [10][12] Group 3 - The company announced a buyback option for the convertible bonds at a price of RMB 100.38 per bond, including accrued interest [16][22] - The buyback period is from December 3 to December 9, 2025, with funds to be disbursed on December 12, 2025 [19][23] - During the buyback period, the convertible bonds will continue to trade but will not be convertible into shares [25]

证券代码：688660 证券简称：电气风电 公告编号：2025-040 上海电气风电集团股份有限公司 2026年度日常关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次2026年度日常关联交易尚需提交股东会审议。 ● 本次日常关联交易对公司的影响：本次公司及其合并报表范围内的子公司和其他主体（以下简称"公 司及其子公司"）拟与各关联人之间发生的交易均为开展日常业务和实际生产经营所需。公司及其子公 司与关联人之间的交易均遵循协商一致、公平交易、互惠互利的原则，不存在损害公司和全体股东利益 的情形。公司及其子公司就关联交易中的采购及销售等业务均有其他市场渠道，不会对关联人形成依 赖。 一、关联交易基本情况 （一）履行的审议程序 第三届董事会于2025年12月06日召开2025年度第四次临时会议审议通过了《2026年度日常关联交易的议 案》，其中同意5票，反对0票，弃权0票，关联董事乔银平、陈术宇、董春英、王勇均予以回避表决。 该议案将提交公司股东会2025年第二次临时会议审议，关联股东上海 ...